TITLE

LUNG ALERT: Budesonide-formoterol reliever therapy in asthma

AUTHOR(S)
Quint, J. K.
PUB. DATE
November 2006
SOURCE
Thorax;Nov2006, Vol. 61 Issue 11, p985
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the study on the use of budesonide-formoterol reliever therapy as an asthma treatment. The subjects were 3394 patients with moderate and severe asthma, which were randomly given budesonide-formoterol maintenance therapy plus one of budesonide-formoterol, formoterol and terbutaline. Findings showed that reduction of severe exacerbation by using budesonide-formoterol maintenance and reliever therapy was not determined.
ACCESSION #
23259079

 

Related Articles

  • It pays to pick beclometasone/formoterol for asthma in Spain.  // PharmacoEconomics & Outcomes News;11/15/2008, Issue 566, p9 

    The article discusses studies being done on the use of beclometasone/formoterol in treating patients with moderate-severe asthma in Spain, presented at the 18th Annual Congress of the European Respiratory Society. Researcher from Spain assessed the efficiency of beclometasone/formoterol against...

  • Review: formoterol increases serious adverse events in children and adults with chronic asthma. Peters, Jay // Evidence Based Medicine;Jun2009, Vol. 14 Issue 3, p12 

    The article presents a study which compares the effects of inhaled formoterol once or twice daily for 12 weeks with placebo or short-acting beta 2 agonists in treating children and adults with chronic asthma. Result shows that both can cause mortality and can cause non-fatal serious adverse...

  • Budesonide plus formoterol associated with better control of persistent asthma control than gold standard therapy.  // Formulary;Aug2007, Vol. 42 Issue 8, p490 

    The article focuses on the therapeutic use of budesonide/formoterol in controlling persistent asthma. Budesonide/formoterol was found as better maintenance and reliever therapy in providing asthma control. The use of these steroids offers a significant better treatment option which has been...

  • Formoterol Oral Inhalation.  // AHFS Consumer Medication Information;Oct2017, p1 

    Formoterol is used to treat wheezing, shortness of breath, and breathing difficulties caused by asthma and chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). It also is used to prevent breathing difficulties (bronchospasm)...

  • SkyePharma: hope worth sharing?  // PharmaWatch: Monthly Review;Dec2005, Vol. 4 Issue 12, p29 

    The article reports that SkyePharma Inc. is developing Flutiform for the U.S. asthma market. Flutiform is a fixed-dose combination of formoterol, a long-acting bronchodilator and fluticasone, an inhaled corticosteroid. The initial indication for Flutiform will be asthma, with a chronic...

  • Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. Price, David B.; Williams, Angela E.; Yoxall, Sally // Respiratory Research;2007, Vol. 8, p46 

    Background: Improving patients' health-related quality of life (HRQoL) is recognized as a fundamental part of asthma management. The aims of this study were to evaluate the long-term efficacy (including symptom-free days and exacerbations) and impact on HRQoL of a stable-dose regimen of...

  • Combined budesonide and formoterol for maintenance and relief provided better asthma control than budesonide for maintenance and terbutaline for relief. Rabe, K. F.; Pizzichini, E.; Ställberg, B. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p138 

    The article presents a study on the effectiveness of the combination of budesonide and formoterol in treating patients with mild to moderate asthma. The result showed that budesonide and formoterol in a single inhaler was more effective than a higher dose of budesonide for maintenance plus...

  • Salbutamol.  // Reactions Weekly;9/29/2007, Issue 1171, p24 

    The article presents a case study of a 41-year-old man, who had a 40 pack/year smoking history and a 3-year history of asthma, experienced bronchoconstriction following inhalation of salbutamol for asthma exacerbation. After receiving methylprednisolone and formoterol, he felt breathless and...

  • Inhaled corticosteroid therapy for patients with persistent asthma: Learnings from studies of inhaled budesonide. Chipps, Bradley E. // Allergy & Asthma Proceedings;May/Jun2009, Vol. 30 Issue 3, p217 

    Inhaled corticosteroids (ICSs) are recommended for patients with asthma who use a short-acting β2-adrenergic agonist more than twice weekly—a key indicator of disease persistency. Much knowledge about the long-term benefits of ICSs in persistent asthma stems from studies of the ICS...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics